THE RARE CANCER RESEARCH FOUNDATION and Caring for Carcinoid Foundation announced up to $300,000 in globally available awards to develop cell lines for intestinal carcinoid and pancreatic neuroendocrine cancer.
These rare cancers have few FDA-approved treatment options. The lack of widely available, validated neuroendocrine cancer cell lines is a major obstacle to neuroendocrine cancer research. The program will feature intestinal carcinoid and pancreatic neuroendocrine cancer as the first awards.
Investigators who create one or more immortal cell lines from intestinal carcinoid and/or pancreatic neuroendocrine tumors are invited to submit the cell line(s) for prompt validation, to establish eligibility, and to initiate the process for repository deposit. Investigators whom the CFCF has funded after 2011 to create cell lines are ineligible for the prize.
Complete submission criteria are available on their website.
